Control of Drug Release from Polymeric Matrices Coated with Poly(DL-lactide) I. Effect of Coasting Substance on the Drug Release in pH 1.2 Hydrochloride Solution

Poly(DL-lactide)로 피막된 고분자 매트릭스로부터 약물 방출 조절 I. pH 1.2 염산 용액에서 피막물질이 약물방출에 미치는 영향

  • 나재운 (순천대학교 공과대학 고분자공학과) ;
  • 박영훈 (순천대학교 공과대학 고분자공학과)
  • Published : 1999.06.01

Abstract

The polymeric matrices coated with poly(DL-lactide) were prepared using chitosan derivatives such as chitosan, chitosan hydrochloride, and sulfonated chitosan for application of drug delivery systems. The drug release study using prednisolone as a model drug was performed in the hydrochloride solution at pH 1.2. The release rate of drug was decreased according to the increased content of matrices. The release rate of prednisolone according to the kinds of polymeric matrices coated were decreased in the order to chitosan, sulfonated chitosan, and chitosan hydrochloride. Drug release rate of polymeric matrices coated with poly(DL-lactide) was not only two times slower than noncoated one, but also the burst effect of initial period of drug release was decreased in comparison with noncoated one. From these results, it was expected that these formulations based on the chitosan derivative matrices coasted with poly(DL-lactide) were acceptable drug delivery devices for a sustained-release dosage form of drug.

Poly(DL-lactide)로 피막된 고분자 매트릭스를 약물전달시스템에 이용하기 위해 키토산, 키토산 염산염 및 술폰화 키토산으로 제조되었다. 모델 약물로 프레드니솔론을 사용하는 본 약물방출에 관한 연구는 pH 1.2 염산 용액에서 실험을 하였다. 약물 방출 속도는 고분자 매트릭스의 함유량이 증가할 수록 감소하였다. 피막된 고분자 매트릭스의 종류에 따라 지연된 약물의 방출시간은 키토산의 경우가 가장 길었으며, 술폰화 키토산, 키토산 염산염의 순서였다. DL-PLA로 피막된 고분자 매트릭스가 피막되지 않는 고분자 매트릭스 보다 약물 방출시간이 2배 정도의 지연되었을 뿐만 아니라 초기에 약물 과잉방출 현상도 작아 피막된 경우가 방출 조절형 제재로서 더 바람직한 결과를 보였다. 따라서 DL-PLA로 피막된 고분자 매트릭스는 장시간의 약물 방출을 위한 약물전달체로써의 응용이 기대된다.

Keywords

References

  1. New Facets Fes. Sci. v.212 Chitin Austin, P. R.;C. J. Brine;J. E. Castle;J. P. Zikakis
  2. Arch Inter. Physiol. Biochem v.66 Recherches sur les Chitinases, Ⅰ. Dosage Nephelometrique et Production de Chitinase par des Streptomycetes Jeuniaux, C.
  3. Chitin Muzzarelli, R. A. A.
  4. Food Technol. v.38 The Use of Chitinous Polymers in Food Knorr, D.
  5. Drug Parameters Improtant for Transdermal Deliverv v.3 Guy, R. H.;J. Hadgraft
  6. Polymeric Delivery System Properties and Applications Polymer Delivery Systems Concepts Jocobs, I. C.;N. S. Mason;Magda, A. E.(ed.);David, M. P.(ed.)
  7. Drug Delivery Systems Johson, P.;J. G. Lioyd-Jones
  8. Chem. Pharm. Bull. v.29 The Use of Chitin and Chitosan as Drug Carriers Miayzaki, S.;K. Ishii;T. Nadai
  9. Chem. Pharm. Bull. v.30 Directly Compressed Tablets Containing Chitin or Chitosan in Addition to Lactose or Potato Starch Sawayanagi, Y.;N. Nambu;T. Nagai
  10. J. Korean Chem. Soc. v.37 Preparation and Evaluation of Antibacterial Transdermal Device using Chitosan Matrices Kim, S. I.;J. W. Na
  11. J. Korean Ind. & Eng. Chem. v.6 Control of Durg Release using Chitosan Derivatives Cha, W. S.;S. I. Kim;J. W. Ana;D. B. Lee
  12. Ph.D. Thesis, University of Liverpool In Vivo and In Vitro Studies of Biodegradable Polymers for Use in Medicine and Surgery Reed, A. M.
  13. Aust. J. Biol. Sci. v.15 Studies on Chitin Hackman, R. H.
  14. U.S. Patent 2072771 Chemical Products and Process of Preparing the Same Rigby, G. W.
  15. Polymer (korea) v.9 Chitosan-Based Chelating Polymers: There Synthesis and Metal Ion Adsorption Characeristics Kim, Y. M.;K. S. Chio
  16. J. Am. Chem. Soc. v.81 The Sulfonation of Chitosan Wolfron, M. L.;T. H. Shen
  17. Biodegradable Polymers as Drug Delivery Systems Controlled Release of Bioactive Agents from Lactide/Glycolide Polymers Lewis, D. H.;Mark, C.(ed.);Robert, L.(ed.)
  18. Biosci. Biotech Biochem. v.56 Stimulation of IgM Production in Human-Human Hybridoma HB4C5 Cells by Chitosan Maeda, M.;H. Murakami;H. Ohta;M. Tajima
  19. Proc. 1st, Int'l Conf. Chitin/Chitosan Rutherford Ⅲ, F. A.;P. R. Austin